Table 1.
Number of significant KEGG pathways using different pathway resources.
| Pathway Resource | Number of Significant Primary Cancer-Related Pathways | Number of Significant Metastatic Cancer-Related Pathways |
|---|---|---|
| Raw pathways | 17 | 24 |
| Expanded pathways by primary cancer Bayesian network 1 time | 22 | 13 |
| Expanded pathways by primary cancer Bayesian network 2 times | 41 | 0 |
| Expanded pathways by primary cancer Bayesian network 3 time | 55 | 0 |
| Expanded pathways by metastatic cancer Bayesian network 1 time | 11 | 34 |
| Expanded pathways by metastatic cancer Bayesian network 2 times | 5 | 49 |
| Expanded pathways by metastatic cancer Bayesian network 3 time | 1 | 48 |